Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Lucatumumab

🥰Excellent
Catalog No. T76729Cas No. 903512-50-5
Alias HCD122, HCD 122, CHIR-12.12

Lucatumumab (HCD122) is a fully human anti-CD40 monoclonal antibody with antitumor activity that blocks the interaction of CD40L with CD40 and inhibits the CD40/CD40L-mediated signaling pathway for the study of chronic lymphocytic leukemia (CLL) and multiple myeloma.

Lucatumumab

Lucatumumab

🥰Excellent
Purity: 95%
Catalog No. T76729Alias HCD122, HCD 122, CHIR-12.12Cas No. 903512-50-5
Lucatumumab (HCD122) is a fully human anti-CD40 monoclonal antibody with antitumor activity that blocks the interaction of CD40L with CD40 and inhibits the CD40/CD40L-mediated signaling pathway for the study of chronic lymphocytic leukemia (CLL) and multiple myeloma.
Pack SizePriceAvailabilityQuantity
1 mg$163In Stock
5 mg$448In Stock
10 mg$728In Stock
25 mg$1,080In Stock
50 mg$1,480In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Concentration:5.37 mg/mL
Purity:95%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Lucatumumab (HCD122) is a fully human anti-CD40 monoclonal antibody with antitumor activity that blocks the interaction of CD40L with CD40 and inhibits the CD40/CD40L-mediated signaling pathway for the study of chronic lymphocytic leukemia (CLL) and multiple myeloma.
In vitro
Lucatumumab (0.001-10 μg/mL; 4 hours) lysed B-cell chronic lymphocytic leukemia (B-CLL) cells by antibody-dependent cell-mediated cytotoxicity (ADCC) action, achieving a mean maximum lysis rate of 49%. [1]
Lucatumumab (0.1-10 μg/mL; 3 days) was able to decrease CD40L-induced signaling and reduce B-CLL cell viability. [1]
Lucatumumab (10 μg/mL; 24 hours) is able to inhibit cytokine secretion by B-CLL cells. [1]
AliasHCD122, HCD 122, CHIR-12.12
Chemical Properties
Cas No.903512-50-5
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Lucatumumab | purchase Lucatumumab | Lucatumumab cost | order Lucatumumab | Lucatumumab in vitro